早期抗生素暴露与精神及神经认知结局风险:系统综述与荟萃分析
该系统综述与荟萃分析共纳入30项研究(n=7047853),评估产前及出生后0-2岁抗生素暴露与后续精神及神经认知结局的关联。产前暴露与孤独症谱系障碍(ASD)和注意缺陷多动障碍(ADHD)风险相关,早期童年暴露与ASD、ADHD及重性抑郁障碍(MDD)风险相关;但采用同胞对照的研究未显示早期暴露与ASD或ADHD的显著关联,MDD无同胞对照研究。GRADE评价除一项外均为极低确定性。
要点
- 产前抗生素暴露与ASD(OR 1.09,95%CI 1.02-1.16)和ADHD(OR 1.19,95%CI 1.11-1.27)风险相关。
- 早期童年抗生素暴露与ASD(OR 1.19,95%CI 1.01-1.40)、ADHD(OR 1.33,95%CI 1.20-1.48)和MDD(OR 1.29,95%CI 1.04-1.60)风险相关。
- 采用同胞对照的研究未显示早期暴露与ASD或ADHD的显著关联;MDD无同胞对照研究。
核心结论
- 早期抗生素使用与后续神经发育结局的关联证据较弱,且在同胞对照亚组分析中减弱。
- 这些关联可能由遗传和家庭混杂因素解释,未采用同胞对照的研究需谨慎解读。
研究设计与样本
- 系统综述与荟萃分析,检索Medline、PsychINFO和Excerpta Medica数据库,检索日期为2023年11月20日。
- 共纳入30项研究,总样本量n=7047853名参与者。
- 使用纽卡斯尔-渥太华量表评估偏倚风险,使用GRADE确定性评估评价证据质量。
主要发现
- 产前抗生素暴露与ASD风险相关(OR 1.09,95%CI 1.02-1.16)。
- 产前抗生素暴露与ADHD风险相关(OR 1.19,95%CI 1.11-1.27)。
- 早期童年抗生素暴露与ASD风险相关(OR 1.19,95%CI 1.01-1.40)。
- 早期童年抗生素暴露与ADHD风险相关(OR 1.33,95%CI 1.20-1.48)。
- 早期童年抗生素暴露与MDD风险相关(OR 1.29,95%CI 1.04-1.60);采用同胞对照的研究未显示早期暴露与ASD或ADHD的显著关联,MDD无同胞对照研究。
关键数值与推荐
- GRADE确定性评估:除一项荟萃分析外,所有荟萃分析均评为极低确定性,主要因方法学和统计学异质性。
临床怎么用
- 原文未据此给出推荐。
局限性
- 所有荟萃分析除一项外均评为极低确定性,主要因方法学和统计学异质性。
- 采用同胞对照的研究未显示早期暴露与ASD或ADHD的显著关联,MDD无同胞对照研究,关联可能由遗传和家庭混杂因素解释。
- 未采用同胞对照的研究需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The prenatal and early-life periods pose a crucial neurodevelopmental window whereby disruptions to the intestinal microbiota and the developing brain may have adverse impacts. As antibiotics affect the human intestinal microbiome, it follows that early-life antibiotic exposure may be associated with later-life psychiatric or neurocognitive outcomes. AIMS: To explore the association between early-life (in utero and early childhood (age 0-2 years)) antibiotic exposure and the subsequent risk of psychiatric and neurocognitive outcomes. METHOD: A search was conducted using Medline, PsychINFO and Excerpta Medica databases on 20 November 2023. Risk of bias was assessed using the Newcastle-Ottawa scale, and certainty was assessed using the grading of recommendations, assessment, development and evaluation (GRADE) certainty assessment. RESULTS: Thirty studies were included (n = 7 047 853 participants). Associations were observed between in utero antibiotic exposure and later development of autism spectrum disorder (ASD) (odds ratio 1.09, 95% CI: 1.02-1.16) and attention-deficit hyperactivity disorder (ADHD) (odds ratio 1.19, 95% CI: 1.11-1.27) and early-childhood exposure and later development of ASD (odds ratio 1.19, 95% CI: 1.01-1.40), ADHD (odds ratio 1.33, 95% CI: 1.20-1.48) and major depressive disorder (MDD) (odds ratio 1.29, 95% CI: 1.04-1.60). However, studies that used sibling control groups showed no significant association between early-life exposure and ASD or ADHD. No studies in MDD used sibling controls. Using the GRADE certainty assessment, all meta-analyses but one were rated very low certainty, largely owing to methodological and statistical heterogeneity. CONCLUSIONS: While there was weak evidence for associations between antibiotic use in early-life and later neurodevelopmental outcomes, these were attenuated in sibling-controlled subgroup analyses. Thus, associations may be explained by genetic and familial confounding, and studies failing to utilise sibling-control groups must be interpreted with caution. PROSPERO ID: CRD42022304128.
引用
- Green JE, Wrobel A, Todd E, et al. Early antibiotic exposure and risk of psychiatric and neurocognitive outcomes: systematic review and meta-analysis. Br J Psychiatry. 2024. PMID: 39658347. doi:10.1192/bjp.2024.121
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。